RA Capital Management, L.P., Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 32,876 shares at $8.88 ($292K) on 2026-06-25, disclosed to the SEC on 2026-06-29.
Open-market purchase of $292k ARTV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.88 | 31,000 | $275K | 94.2% |
| 2 | $8.98 | 1,876 | $17K | 5.8% |
| Total | $8.89 avg | 32,876 | $292K | 100% |
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $2.6M | — | Filing → |